Physician profile
Brian D Walker
NPI 1386140101
$3,754.73
in general payments reported to CMS, 2019-2025
18 companies · $828 in 2025
The $828 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,080 · 2022: $683 · 2023: $837 · 2024: $326 · 2025: $828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,991.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,195.69 | 2021-2025 | Ngenuity, Argos, Rocklatan |
| Abbvie INC. | $382.16 | 2022-2025 | Durysta |
| Bausch & Lomb Americas INC. | $355.27 | 2023-2025 | Miebo, Xiidra, Scoutpro Osmolarity System |
| Glaukos Corporation | $322.92 | 2021-2022 | |
| Johnson & Johnson Surgical Vision, INC. | $222.62 | 2022-2023 | Tecnis Simplicity, Veritas Vision System, Tecnis Iol |
| Oyster Point Pharma, INC. | $198.84 | 2022-2025 | Tyrvaya |
| Sight Sciences, INC. | $179.06 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Rxsight INC | $169.68 | 2024-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge |
| Horizon Therapeutics Plc | $157.66 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $145.70 | 2022-2025 | Cequa |
| Allergan, INC. | $99.95 | 2021 | |
| New World Medical,INC. | $97.97 | 2022-2025 | Streamline, Kahook Dual Blade, Ahmed Glaucoma Valve |
| Thea Pharma INC. | $88.53 | 2023-2025 | Iyuzeh |
| Lensar, INC. | $45.25 | 2023 | Lensar Laser System |
| Amgen INC. | $29.47 | 2025 | Tepezza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $28.43 | 2025 | Xdemvy |
| Astellas Pharma US INC | $17.94 | 2024 | Izervay |
| Ani Pharmaceuticals, INC. | $17.59 | 2025 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.